Dr' J'K' Pal - PowerPoint PPT Presentation

1 / 9
About This Presentation
Title:

Dr' J'K' Pal

Description:

DEFINITION : Reduction in the functional mass of circulating red ... 3. Ms. Sunita Shankar. Financial support : CSIR ; UGC; DBT. Publication & Recognition: ... – PowerPoint PPT presentation

Number of Views:70
Avg rating:3.0/5.0
Slides: 10
Provided by: Zoo58
Category:
Tags: pal | sunita

less

Transcript and Presenter's Notes

Title: Dr' J'K' Pal


1
A MOLECULAR DIAGNOSTIC FOR ANAEMIA, HEAVY METAL
TOXICITY HEMATOLOGICAL DISORDERS

Dr. J.K. Pal Department of Biotechnology,
University of Pune email jkpal_at_unipune.ernet.in
Phone 20-5672248
2
ANAEMIA
DEFINITION Reduction in the functional mass of
circulating red blood cells is termed anaemia and
it results in the reduction of blood haemoglobin
level
CAUSE The 3 most common causes are, a) blood
loss, b) increased rate of destruction of
RBC, and c) impaired production of RBC
3
Currently, diagnosis of progressive ANAEMIA is
made by observing increasing numbers of
RETICULOCYTES in the blood
Control
Peripheral blood smear showing increase in
reticulocyte during drug- induced anaemia in
rabbit
During progression of anaemia
4
HRI, A MOLECULAR MARKER FOR DRUG-INDUCED ANAEMIA
(Western blot)
acute anaemia during recovery
during recovery
1 control 2-4 anaemic
5
RETICULOCYTE COUNT VS HRI WESTERN BLOT
1
2
3
4
6
HRI AS A MARKER FOR LEAD-TOXICITY (PCR DETECTION
OF HRI EXPRESSION IN HUMAN K562 ERYTHROID CELLS)
B - (1, marker DNA 2, control 3-5, exposed to
100 ug/ml lead for 2,8 and 16h, respectively)
A - (1, marker DNA 2, control 3-5, exposed to
lead acetate conc. of 10,100 and 500 ug/ml,
respectively)
7
DIP-STICK METHOD FOR PROGNOSTIC DETECTION OF
ANAEMIA
CURRENT WORK IN PROGRESS 1. PURIFICATION OF
HUMAN HRI 2. PREPARATION OF ANTI-HUMAN
HRI MONOCLONAL ANTIBODIES 3. SCREENING OF BLOOD
SAMPLES BY WESTERN BLOT AND RT-PCR 4.
DESIGNING OF DIPSTICK KIT
NEGATIVE CONTROL
HRI VE TEST SAMPLE
HRIVE STANDARD
8
POTENTIAL APPLICATIONS OF THE HRI DIPSTICK
USER FRIENDLY
RAPID (1.5H) EASY ALTER-NATIVE TO EXISTING TESTS
ABILITY TO MONITOR SUCCESS OF DRUG THERAPY
HIGHLY SENSITIVE
MULTIPLE APPLICATIONS (DRUG- AND HEAVY METAL-
TOXICITY, LEUKEMIAS, MALARIA, LEISHMANIASIS)
MINIMUM LAB INFRASTRUCTURE OR EQUIPMENT NEEDED
9
OTHER RESEARCHERS IN THE TEAM 1. Dr. Sanjay
Anand 3. Mr. Angshuman Sarkar 3. Ms. Sunita
Shankar Financial support CSIR UGC
DBT Publication Recognition 1. J. Biosci.
22, 287-298 (1997) Received Best paper of 1997-
A. Krishnamurthy Award from The Society of
Biological Chemists, India. ((
Write a Comment
User Comments (0)
About PowerShow.com